François Guérard (F Guérard)

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

RSC medicinal chemistry

Accounts of chemical research

Cancers

CNRS Délégation Bretagne et Pays de Loire

Université de Nantes (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CNRS Délégation Bretagne et Pays de Loire Oct 01 2017

France

Research associate (Chargé de recherche) :: Loire Atlantique

Education History

Université de Nantes Oct 01 2006 - Sep 30 2010

France

PHD

Publications

Thibault Yssartier, Lu Liu, Sylvain Pardoue, Jean-Yves Le Questel, François Guérard, Gilles Montavon, Nicolas Galland
In vivo stability of 211 At-radiopharmaceuticals: on the impact of halogen bond formation. RSC medicinal chemistry 15 (1) (2023)
Thibault Yssartier, Lu Liu, Sylvain Pardoue, Jean-Yves Le Questel, François Guérard, Gilles Montavon, Nicolas Galland
In vivo stability of 211 At-radiopharmaceuticals: on the impact of halogen bond formation. RSC medicinal chemistry 15 (1) (2023)
Clémence Maingueneau, Marion Berdal, Romain Eychenne, Joëlle Gaschet, Michel Cherel, Jean-François Gestin, François Guérard
211 At and 125 I-Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (11) (2022)
François Guérard, Clémence Maingueneau, Lu Liu, Romain Eychenne, Jean-François Gestin, Gilles Montavon, Nicolas Galland
Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals. Accounts of chemical research (2021)
Romain Eychenne, Michel Cherel, Férid Haddad, François Guérard, Jean-François Gestin
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 13 (6) (2021)
François Guérard, Yong-Sok Lee, Pr Raphael Tripier, Lawrence P Szajek, Jeffrey R Deschamps, Martin W Brechbiel
Reply to the 'Comment on "Investigation of Zr(iv) and 89Zr(iv) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging"' by A. Bianchi and M. Savastano, Chem. Commun., 2020, 56, D0CC01189D. Chemical communications (Cambridge, England) 56 (83) (2020)
Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, Alain Faivre-Chauvet, Michel Cherel, Joëlle Gaschet, Jean-François Gestin, François Guérard
Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical science 12 (4) (2020)
Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clement Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Cherel
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease. Cancers 12 (9) (2020)
François Guérard, M Beyler, Y-S Lee, Pr Raphael Tripier, J-F Gestin, M W Brechbiel
Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications. Dalton transactions (Cambridge, England : 2003) 46 (14) (2018)
François Guérard, Yong-Sok Lee, Kwamena Baidoo, Jean-François Gestin, Martin W Brechbiel
Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts. Chemistry (Weinheim an der Bergstrasse, Germany) 22 (35) (2016)

François Guérard.css-eqlu8i{font-size:small;padding-left:4px;} (F Guérard)

Publication Activity (10 Years)

Top Topics

Top Venues

François Guérard (F Guérard)